The safety of adjuvants in influenza vaccines during pregnancy: What do we know and why do we need them?

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 3, 2012, Pages 145-146

  Jamieson, Denise J ^a   Rasmussen, Sonja A ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; DISEASE TRANSMISSION; DRUG SAFETY; EDITORIAL; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS A H3N2; MORTALITY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; SEASONAL INFLUENZA; UNITED STATES;

ADJUVANTS, IMMUNOLOGIC; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84865737348     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.07.011     Document Type: Editorial

References (12)

1. L.E. Burney Influenza immunization: statement Public Health Rep 75 1960 944
2. Centers for Disease Control and Prevention Influenza vaccination coverage among pregnant women-United States, 2010-11 influenza season MMWR Morb Mortal Wkly Rep 60 2011 1078 1082
3. P.D. Tamma, K.A. Ault, C. Del Rio, M.C. Steinhoff, N.A. Halsey, S.B. Omer Safety of influenza vaccination during pregnancy Am J Obstet Gynecol 201 2009 547 552
4. P.L. Moro, K. Broder, Y. Zheteyeva Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System Am J Obstet Gynecol 205 2011 473.e1 473.e9
5. B. Pasternak, H. Svanstrom, D. Molgaard-Nielsen Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark BMJ 344 2012 e2794
6. C. Herberts, B. Melgert, J.W. Van Der Laan, M. Faas New adjuvanted vaccines in pregnancy: what is known about their safety? Expert Rev Vaccines 9 2010 1411 1422
7. F. Tavares, I. Nazareth, J.S. Monegal, I. Kolte, T. Verstraeten, V. Bauchau Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study Vaccine 29 2011 6358 6365
8. E. Parretta, B. Ianniello, F. Ferrazin, F. Rossi, A. Capuano Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination Vaccine 29 2011 3708 3713
9. T. Tsai, M.H. Kyaw, D. Novicki, P. Nacci, S. Rai, R. Clemens Exposure to MF59-adjuvanted influenza vaccines during pregnancy- A retrospective analysis Vaccine 28 2010 1877 1880
10. G. Zuccotti, L. Pogliani, E. Pariani, A. Amendola, A. Zanetti Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine JAMA 304 2010 2360 2361
11. T. Heikkinen, J. Young, E. van Beek Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study Am J Obstet Gynecol 207 2012 177.e1 177.e8
12. Centers for Disease Control and Prevention First H3N2 variant virus infection reported for 2012 http://www.cdc.gov/flu/spotlights/h3n2v-variant- utah.htm Accessed June 29, 2012